KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SiriusPoint (SPNT) Preferred Stock Liabilities (2021 - 2024)

Historic Preferred Stock Liabilities for SiriusPoint (SPNT) over the last 4 years, with Q3 2024 value amounting to $58.4 million.

  • SiriusPoint's Preferred Stock Liabilities fell 580.65% to $58.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $58.4 million, marking a year-over-year decrease of 580.65%. This contributed to the annual value of $67.3 million for FY2023, which is 1142.38% up from last year.
  • According to the latest figures from Q3 2024, SiriusPoint's Preferred Stock Liabilities is $58.4 million, which was down 580.65% from $72.6 million recorded in Q2 2024.
  • SiriusPoint's 5-year Preferred Stock Liabilities high stood at $135.0 million for Q1 2021, and its period low was $47.0 million during Q1 2023.
  • Moreover, its 4-year median value for Preferred Stock Liabilities was $67.3 million (2023), whereas its average is $76.0 million.
  • Its Preferred Stock Liabilities has fluctuated over the past 5 years, first plummeted by 5851.06% in 2022, then surged by 7702.13% in 2024.
  • SiriusPoint's Preferred Stock Liabilities (Quarter) stood at $87.8 million in 2021, then tumbled by 31.21% to $60.4 million in 2022, then grew by 11.42% to $67.3 million in 2023, then decreased by 13.22% to $58.4 million in 2024.
  • Its Preferred Stock Liabilities stands at $58.4 million for Q3 2024, versus $72.6 million for Q2 2024 and $83.2 million for Q1 2024.